Curis Lifesciences IPO
Open SmeCurrent GMP
₹9 (+7.03%)
Price Band
₹ 120 – 128
Lot Size
1000
Issue Size
₹27.52 Cr
Minimum Investment
₹256000 (2000 Shares)
Listing Date
14 November 2025
Subscription
74.47x
About the Company
Curis Lifesciences Limited
Incorporation Year: 2010
Headquarters: Sanand, Gujarat, India
Overview:
Curis Lifesciences Limited is a pharmaceutical company engaged in the development, manufacturing, and distribution of a wide range of high-quality pharmaceutical products. The company operates globally and domestically, offering services on a loan license, contract manufacturing, and own brand marketing basis.
Operations:
Curis Lifesciences manufactures pharmaceutical formulations for over 100 corporate clients under loan license and contract manufacturing arrangements. In addition, the company markets its own brands in Yemen and Kenya, serving two international clients under its brand portfolio.
Product Portfolio:
- General pharmaceutical tablets and capsules
- Oral liquids
- External preparations (topical formulations)
- Sterile ophthalmic ointments
Manufacturing Facility:
The company operates a state-of-the-art manufacturing facility located in Sanand, Gujarat, equipped with advanced technology and robust quality assurance systems. The facility complies with stringent regulatory and quality control standards to ensure the safety, efficacy, and reliability of all products.
Workforce:
As of July 31, 2025, Curis Lifesciences Limited employs 95 permanent staff members, comprising skilled professionals across manufacturing, quality assurance, research, and administrative functions.
Promoters
- Mr. Dharmesh Dashrathbhai Patel
- Mr. Siddhant Jayantibhai Pawasia
- Mr. Piyush Gordhanbhai Antala
- Mr. Jaimik Mansukhbhai Patel
Promoters Holding
Holding Pre Issue
92.68%
Holding Post Issue
68.03%
Objects of the Issue
The Company Curis Lifesciences IPO proposes to utilise the Net Proceeds from the Issue towards the following objects.
- Capital Expenditure towards Upgradation/Improvement of our existing Manufacturing Facilities
- Capital Expenditure towards Construction of a Storage Facility
- Pre-payment/Repayment of outstanding Secured Loans
- Product Registrations in other countries
- Funding our Working Capital Requirements
- General Corporate Purposes
Address / Contact Info
Curis Lifesciences Ltd.
PF-23, GIDC Sanand - II,
Industrial Estate,Sanand
Ahmedabad, Gujarat, 382110
Phone: +91 99045 22543
Email: cs@curisls.com
Website: https://curisls.com/
IPO Snapshot
IPO Timeline (Tentative)
IPO Open Date
Friday, 07 November 2025
IPO Close Date
Tuesday, 11 November 2025
Basis of Allotment
Wednesday, 12 November 2025
Initiation of Refunds
Thursday, 13 November 2025
Credit of Shares to Demat
Thursday, 13 November 2025
Listing Date
Friday, 14 November 2025 — NSE & BSE
Important Dates
Open Date
07 November 2025
Close Date
11 November 2025
Basis Of Allotment
12 November 2025
Listing Date
14 November 2025
Financial Performance (₹ in Crores)
| Particular | 31 Dec 2024 | 31 Mar 2024 | 31 Mar 2023 | 31 Mar 2022 |
|---|---|---|---|---|
| Assets | 50.12 | 33.82 | 29.67 | 27.4 |
| Revenue | 36.91 | 35.89 | 36.39 | 23.76 |
| Profit After Tax | 5.3 | 5.03 | 1.85 | 0.49 |
| Net Worth | 15.53 | 5.97 | 0.95 | 0.9 |
| Reserve & Surplus | 9.59 | 5.47 | 0.45 | -1.4 |
| Total Borrowings | 16.16 | 17.09 | 16.19 | 17.62 |
EPS Pre
0.00%
EPS Post
0.00%
P/E Pre
0.00
P/E (Post Issue)
0.00x
Company Financial Information
KPI Information (₹ in Crores)
| Particular | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| ROE % | 145.2 | 8322.25 | -42.52 |
| ROCE % | 34.89 | 20.38 | 17 |
| Debt / Equity | 2.86 | 17.08 | -19.5 |
| RoNW % | 84.12 | 195.28 | -54.5 |
| PbW | 0 | 0 | 0 |
| Pat Margin % | 14.13 | 5.23 | 2.07 |
Return Ratio
IPO Reservations
| Category | Shares Offered | Shares Offered % | Max Allotee |
|---|---|---|---|
| Qualified Institutions | 409000 | 28.54 | 0 |
| Non-Institutional | 308000 | 21.49 | 0 |
| BNII | 206000 | 14.38 | 0 |
| SNII | 102000 | 7.12 | 0 |
| Retail Investors | 716000 | 49.97 | 0 |
| Total | 1433000 | 100 | 0 |
Subscription Status ( Tue, 11 Nov 25 01:57 PM)
| Category | Shares Offered | Shares Bid For | Subscription (x) |
|---|---|---|---|
| Qualified Institutions | 409000 | 39335000 | 96.17x |
| Non-Institutional | 308000 | 35671000 | 115.81x |
| BNII | 206000 | 29512000 | 143.26x |
| SNII | 102000 | 6159000 | 60.38x |
| Retail Investors | 716000 | 31706000 | 44.28x |
| Total | 1433000 | 106712000 | 74.47x |
Subscription figures are updated periodically and may change until issue closing. Data reflects bids placed across exchanges.
Peer Comparision
No Peer Comparision Available
Lot Size & Investment Details
| Application | Lots | Shares | Amount (₹) |
|---|---|---|---|
| Retail (Min) | 2 | 2,000 | 256,000.00 |
| Retail (Max) | 2 | 2,000 | 256,000.00 |
| S-HNI (Min) | 3 | 3,000 | 384,000.00 |
| S-HNI (Max) | 7 | 7,000 | 896,000.00 |
| B-HNI (Min) | 8 | 8,000 | 1,024,000.00 |
Registrar
MUFG Intime India Private Limited ((Link Intime)
91-22-4918 6270
ipo.helpdesk@in.mpms.mufg.com
https://in.mpms.mufg.com/home.html
Book Running Lead Managers
- Swastika Investmart Ltd
RHP Document
DRHP Document
Disclaimer: This data is for informational purposes only and does not constitute investment advice. Figures shown are illustrative sample data.
Frequently Asked Questions
Everything you need to know before applying to an IPO.
Curis Lifesciences IPO is a Book-building IPO worth ₹27.52 crores. The price band is ₹120 to 128 per share. The IPO opens on Fri, Nov 7, 2025 and closes on Tue, Nov 11, 2025. It will be listed on BSE and NSE. MUFG Intime India Private Limited ((Link Intime) is the registrar.
The Curis Lifesciences IPO opens on Fri, Nov 7, 2025 and closes on Tue, Nov 11, 2025
Curis Lifesciences IPO Price Band is ₹120 to 128.
Curis Lifesciences IPO lot size is 1000, and the minimum amount required for application is ₹256000.
The minimum investment for Curis Lifesciences IPO is approximately ₹256000 based on the upper price band.
To apply for the Curis Lifesciences IPO, investors can use the ASBA (Application Supported by Blocked Amount) process via their bank's net banking or apply through UPI using a registered broker or trading app. The IPO is available in retail, HNI, and institutional investor categories. Investors must select the lot size, enter bid details within the price band, and submit their application before the IPO closing date of Tue, Nov 11, 2025. After submission, funds are blocked until the basis of allotment of Curis Lifesciences IPO is finalised.
Curis Lifesciences IPO issue size is ₹27.52 crores.
Curis Lifesciences IPO allotment date is Sat, Jun 27, 2026.
The registrar for Curis Lifesciences IPO is MUFG Intime India Private Limited ((Link Intime). Investors can go to MUFG Intime India Private Limited ((Link Intime) website for IPO allotment status, refund processing, and other queries related to Curis Lifesciences IPO through their official website or helpline.
The Curis Lifesciences IPO GMP (Grey Market Premium) is ₹9 as of Fri, Nov 14, 2025. Based on the upper price band of ₹128 per share, the estimated Curis Lifesciences IPO listing price is ₹137, indicating a potential listing gain of approximately 31% over the issue price.